TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: LFS (Leukemia-Free Survival)
Endpoint domain: Mortality/survival
Primary endpoint: OS (Overall Survival)
Endpoint domain: Mortality/survival
Primary endpoint: risk for caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in PVS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in NYHA class
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: LDL-cholesterol changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: F2-isoprostanes changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean urinary excretion of 5-HMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coefficients of variation for AUC and C(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total PAF duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibrillatory frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: workload capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: anginal attacks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cumulative ST-segment depression during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive response to stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain related to the device
Endpoint domain: Adverse events/effects
Primary endpoint: Wound infection or haematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of compensatory hyperhidrosis (CH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success on follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAM-D₁₇ score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SDS score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 2-year recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Progression of ACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Worsening of eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: virologic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of weight restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin production (HOMA Beta)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 24-hour ambulatory blood pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of ventilation directed to the dependent lung
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Temporal ventilation distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cardiopulmonary bypass time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cross-clamp time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival at three years
Endpoint domain: Mortality/survival
Primary endpoint: Quality of Life (QOL) discussions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: neonatal death before discharge
Endpoint domain: Mortality/survival
Primary endpoint: Mindful attention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Occurrence of a seizure lasting ≥20 seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Shortest seizure duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Treatment success by freedom-from-failure criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Rate of abnormal LBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic/Diastolic BP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Kmax change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manifest spherical equivalent refraction change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attentional functioning away from substance-related stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance craving levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: hospital-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite incidence of death or myocardial infarction at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Composite of death, myocardial infarction, or urgent target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: PRL response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: curative rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: bacteriostatic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Anxiety symptom frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall rate of institutional deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious non-AIDS events
Endpoint domain: Mortality/survival
Primary endpoint: Opportunistic diseases (OD)
Endpoint domain: Mortality/survival
Primary endpoint: median liver specific disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Parent satisfaction with therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for single-dose IM therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Implementation of process indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum VEGF-D level > 800 pg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower survival rate
Endpoint domain: Mortality/survival
Primary endpoint: composite rate of engagement in benzodiazepine use reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal heart rate (HR) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maternal cardiac output (CO) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of new ischaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Activities of daily living (ADL) improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area Under the Curve for VAS pain (0 to 4h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year prostate cancer specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: striatal [(11) C]NPA BP(ND)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % R(HIGH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measures of HIV Information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Beliefs about Condom Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cormack grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of FLV% and GLV%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work absenteeism and presenteeism
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Household days lost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Days lost due to RA for participation in family, social, and leisure activities
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Triazolam area under the plasma concentration curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digit Symbol Substitution Test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electroencephalographic beta amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocyte cytotoxic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Circulating monocytes count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean MPA‐AUC0‐12 value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICIQ-FLUTS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UDI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative haemostasis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative haemoglobin-level variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: beneficial change in behaviour
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of 11-15-year-olds reporting medicine use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective memory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subjective memory function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Psoriasis Area and Severity Index percent improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone turnover markers (CTX, osteocalcin, P1NP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Circulating sclerostin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: stereotypy counts (STC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stereotypy time (STT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total distance traveled (TDT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of dye on the trachea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leakage of fluid around the cuffs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score on the Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time lapse before demand for oral analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nasal mucosal swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustain behavior changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of participants finding competitive work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Follow up attendance rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: arrests
Endpoint domain: Mortality/survival
Primary endpoint: incarcerations
Endpoint domain: Mortality/survival
Primary endpoint: major offences
Endpoint domain: Mortality/survival
Primary endpoint: Need for postoperative blood product transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return of PIIIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number, duration, and propagation velocity of PIIIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: NW and AUC values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hemodynamic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of plasma endotoxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of DAO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cognitive functions (MMSE, ADAS-cog)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Daily activities (IADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Behavioural symptoms (NPI-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Student ranking in favour of lecture format
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lecturer-student interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total cost for 100 min general anaesthesia
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of PONV in the PACU
Endpoint domain: Adverse events/effects
Primary endpoint: Bioavailability variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat mass (FM) gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in RR adjusted for age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of high-grade prostate cancer (PCa)
Endpoint domain: Mortality/survival
Primary endpoint: Risk of total prostate cancer (PCa)
Endpoint domain: Mortality/survival
Primary endpoint: Risk of low-grade prostate cancer (PCa)
Endpoint domain: Mortality/survival
Primary endpoint: average change from baseline in muscle soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average interference with sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Popliteal venous flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: reduced symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perception of stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: greater coping skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Medication changes due to PPOs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication changes due to PIMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pleasure rating during intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical periodontal parameters improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear and anxiety decrease
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Limb fat recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N140 amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction from baseline in SBP of > or = 10 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Final SBP/DBP reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Energetic arousal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Valence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Paid employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Rate of RAO (Radial Artery Occlusion)
Endpoint domain: Mortality/survival
Primary endpoint: Active bleeding after compression removal
Endpoint domain: Adverse events/effects
Primary endpoint: mean FEV(1) AUC(bl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean change from baseline in morning predose FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulmonary vascular resistance decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time until response to nitric oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trauma knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Regimen Problems (MRPs) identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes to patients' medication regimens or management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patient satisfaction with pharmacist home visits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: anterior chamber depth changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: myopic shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: refraction stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Increases in serum creatinine levels to > 2 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increases in serum bilirubin levels to > 2 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSNA burst rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined global symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog scale (VAS) of combined global symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Deviation (MD) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pattern Standard Deviation (PSD) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of NIV support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of supplementary oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of BPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: symmetry of MRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity to stimulant-induced euphoria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: return rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of time with satisfactory sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time from sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ERI (Erythropoiesis Stimulating Agent Resistance Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: b2MG (Beta-2-microglobulin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiotherapy quality rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retraction of incisors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anchorage loss of molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of internal jugular vein puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of preventive care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of Fusarium hyphae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Inhibition of Fusarium sporulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Modified Aldrete Recovery Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction of pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of joint function (Lysholm-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of joint stiffness (Womac part B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity in detecting vestibular schwannoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gastric lipolysis level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: compliance with the procedure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reproducibility of facial deformity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: laxative or suppository use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: episodes of painful defecation per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes